Over 80 lawsuits relating to allegedly ineffective oral decongestants, such as Sudafed PE and Tylenol Cold & Flu, are now set to be presided over by U.S. District Judge Brian Cogan in Brooklyn, New York.
The U.S. Judicial Panel on Multidistrict Litigation announced the consolidation of these cases on Wednesday. The lawsuits have targeted numerous corporations, totaling more than 20. Parties named in these lawsuits include industry giants such as manufacturer Johnson & Johnson Consumer Inc., Procter & Gamble Co., as well as retail entities Amazon.com Inc. and CVS Pharmacy Inc.
These companies reportedly advocated for the transfer of these cases to either the Eastern District of New York or the Southern District of New York, the former being the venue now selected. For more details, refer to the original article
here.
Among the innumerable products and brands implicated in these lawsuits, the oral decongestant medications contain a common ingredient: phenylephrine. This group of suits will contribute to the growing field of jurisprudence on consumer rights, product efficacy, and the obligations of manufacturers and retailers toward their customers. Each of these aspects, in due course, will be seen playing out in the Eastern District of New York.